MEDIA_REFRESH_DATA_PRESS_RELEASE
Media
U.S. News Room
Press Releases
Tue Dec 10 00:00:00 GMT-05:00 2024
QuANTUM-Wild Phase 3 Trial of VANFLYTA® Initiated in Patients with Newly Diagnosed FLT3-ITD Negative AML

Mon Dec 09 00:00:00 GMT-05:00 2024
Daiichi Sankyo Statement on the Passing of Toshinori Agatsuma, PhD

Mon Dec 09 00:00:00 GMT-05:00 2024
Datopotamab Deruxtecan Granted Breakthrough Therapy Designation in U.S. for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer

Thu Dec 05 00:00:00 GMT-05:00 2024
Datopotamab Deruxtecan Demonstrated Meaningful Clinical Activity in Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer in TROPION-Lung05 and TROPION-Lung01 Pooled Analysis

Mon Dec 02 00:00:00 GMT-05:00 2024
Daiichi Sankyo Highlights Progress Across Oncology Portfolio in Multiple Solid and Blood Cancers at ESMO Asia, SABCS and ASH

Fri Nov 22 00:00:00 GMT-05:00 2024
Daiichi Sankyo Joins with LabCentral Community as Platinum Sponsor

Wed Nov 13 00:00:00 GMT-05:00 2024
Daiichi Sankyo to Showcase TURALIO® Research in Patients with Tenosynovial Giant Cell Tumor at CTOS

Tue Nov 12 00:00:00 GMT-05:00 2024
Datopotamab Deruxtecan New BLA Submitted for Accelerated Approval in the U.S. for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer

Fri Nov 08 00:00:00 GMT-05:00 2024
ENHERTU® Receives Prestigious 2024 Prix Galien USA Award for Best Biotechnology Product
